Novo Nordisk
NVO
#78
Rank
HK$1.655 T
Marketcap
HK$372.57
Share price
-0.27%
Change (1 day)
-55.29%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): HK$162.53 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are HK$47.21 Billion. In 2024 the company made an earning of HK$147.33 Billion, an increase over its 2023 earnings that were of HK$119.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$162.53 B10.32%
2024 HK$147.33 B22.84%
2023 HK$119.93 B57.81%
2022 HK$76.00 B5.24%
2021 HK$72.22 B12.38%
2020 HK$64.26 B13.11%
2019 HK$56.81 B-3.45%
2018 HK$58.84 B1.88%
2017 HK$57.75 B4.3%
2016 HK$55.37 B10.32%
2015 HK$50.19 B7.47%
2014 HK$46.70 B3.4%
2013 HK$45.16 B19.09%
2012 HK$37.93 B15.58%
2011 HK$32.81 B16.58%
2010 HK$28.15 B25.66%
2009 HK$22.40 B10.68%
2008 HK$20.24 B55.82%
2007 HK$12.99 B7.02%
2006 HK$12.13 B19.05%
2005 HK$10.19 B10.55%
2004 HK$9.22 B
2002 HK$6.33 B-14.39%
2001 HK$7.39 B-52.82%
2000 HK$15.67 B250%
1999 HK$4.47 B31.21%
1998 HK$3.41 B34.31%
1997 HK$2.54 B11.46%
1996 HK$2.27 B9.03%
1995 HK$2.09 B-3.15%
1994 HK$2.15 B-0.67%
1993 HK$2.17 B45.38%
1992 HK$1.49 B-13.81%
1991 HK$1.73 B37.12%
1990 HK$1.26 B-0.79%
1989 HK$1.27 B26.2%
1988 HK$1.01 B24.97%
1987 HK$0.80 B-0.9%
1986 HK$0.81 B-7.78%
1985 HK$0.88 B24.87%
1984 HK$0.70 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$92.26 B-43.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$175.18 B 7.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$62.53 B-61.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$70.84 B-56.34%๐Ÿ‡ซ๐Ÿ‡ท France